Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes

Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes Susan Sam , MD 1 , Steven Haffner , MD 2 , Michael H. Davidson , MD 3 , Ralph B. D'Agostino, Sr. , MD 4 , Steven Feinstein , MD 5 , George Kondos , MD 6 , Alfonso Perez , MD 7 and Theodore Mazz...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 32; no. 10; pp. 1916 - 1920
Main Authors Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph B., Feinstein, Steven, Kondos, George, Perez, Alfonso, Mazzone, Theodore
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.10.2009
Subjects
men
R&D
Online AccessGet full text
ISSN0149-5992
1935-5548
1935-5548
DOI10.2337/dc09-0412

Cover

Loading…
Abstract Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes Susan Sam , MD 1 , Steven Haffner , MD 2 , Michael H. Davidson , MD 3 , Ralph B. D'Agostino, Sr. , MD 4 , Steven Feinstein , MD 5 , George Kondos , MD 6 , Alfonso Perez , MD 7 and Theodore Mazzone , MD 1 1 Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Illinois, Chicago, Illinois; 2 Department of Medicine, University of Texas Health Science Center, San Antonio, Texas; 3 Pritzker School of Medicine, University of Chicago, Chicago, Illinois; 4 Department of Mathematics, Statistics and Consulting Unit, Boston University, Boston, Massachusetts; 5 Department of Medicine, Section of Cardiology, Rush University Medical Center, Chicago, Illinois; 6 Department of Medicine, Section of Cardiology, University of Illinois College of Medicine, Chicago, Illinois; 7 Takeda Global Research and Development, Deerfield, Illinois. Corresponding author: Susan Sam, susansam{at}uic.edu . Abstract OBJECTIVE Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat. RESEARCH DESIGN AND METHODS We examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of ≥177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference ≤90 cm in men or ≤85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides ≥177 mg/dl, n = 127). RESULTS Subjects in group 3 had significantly higher visceral fat ( P < 0.0001), A1C ( P < 0.01), and coronary artery calcium ( P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number. CONCLUSIONS The presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received March 3, 2009. Accepted July 7, 2009. © 2009 by the American Diabetes Association.
AbstractList Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat. We examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of > or =177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference < or =90 cm in men or < or =85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides > or =177 mg/dl, n = 127). Subjects in group 3 had significantly higher visceral fat (P < 0.0001), A1C (P < 0.01), and coronary artery calcium (P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number. The presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes.
Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat. We examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of ≥ 177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference ≤90 cm in men or ≤85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides ≥177 mg/dl, n = 127). Subjects in group 3 had significantly higher visceral fat (P < 0.0001), A1C (P < 0.01), and coronary artery calcium (P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number. The presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes.
Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes Susan Sam , MD 1 , Steven Haffner , MD 2 , Michael H. Davidson , MD 3 , Ralph B. D'Agostino, Sr. , MD 4 , Steven Feinstein , MD 5 , George Kondos , MD 6 , Alfonso Perez , MD 7 and Theodore Mazzone , MD 1 1 Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Illinois, Chicago, Illinois; 2 Department of Medicine, University of Texas Health Science Center, San Antonio, Texas; 3 Pritzker School of Medicine, University of Chicago, Chicago, Illinois; 4 Department of Mathematics, Statistics and Consulting Unit, Boston University, Boston, Massachusetts; 5 Department of Medicine, Section of Cardiology, Rush University Medical Center, Chicago, Illinois; 6 Department of Medicine, Section of Cardiology, University of Illinois College of Medicine, Chicago, Illinois; 7 Takeda Global Research and Development, Deerfield, Illinois. Corresponding author: Susan Sam, susansam{at}uic.edu . Abstract OBJECTIVE Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat. RESEARCH DESIGN AND METHODS We examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of ≥177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference ≤90 cm in men or ≤85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides ≥177 mg/dl, n = 127). RESULTS Subjects in group 3 had significantly higher visceral fat ( P < 0.0001), A1C ( P < 0.01), and coronary artery calcium ( P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number. CONCLUSIONS The presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes. Footnotes The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Received March 3, 2009. Accepted July 7, 2009. © 2009 by the American Diabetes Association.
Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat.OBJECTIVEGreater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat.We examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of > or =177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference < or =90 cm in men or < or =85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides > or =177 mg/dl, n = 127).RESEARCH DESIGN AND METHODSWe examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of > or =177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference < or =90 cm in men or < or =85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides > or =177 mg/dl, n = 127).Subjects in group 3 had significantly higher visceral fat (P < 0.0001), A1C (P < 0.01), and coronary artery calcium (P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number.RESULTSSubjects in group 3 had significantly higher visceral fat (P < 0.0001), A1C (P < 0.01), and coronary artery calcium (P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number.The presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes.CONCLUSIONSThe presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes.
OBJECTIVE: Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always identify individuals with increased visceral fat. RESEARCH DESIGN AND METHODS: We examined 375 subjects with type 2 diabetes from the CHICAGO cohort for presence of hypertriglyceridemic waist phenotype (waist circumference >90 cm in men or >85 cm in women, in conjunction with a plasma triglyceride concentration of greater-than-or-equal177 mg/dl) to determine its usefulness for identifying subjects with increased amounts of visceral fat. We divided subjects into three groups: group 1 (low waist circumference and low triglycerides; waist circumference [less-than or equal to]90 cm in men or [less-than or equal to]85 cm in women and triglyceride <177 mg/dl, n = 18), group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230), and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides greater-than-or-equal177 mg/dl, n = 127). RESULTS: Subjects in group 3 had significantly higher visceral fat (P < 0.0001), A1C (P < 0.01), and coronary artery calcium (P < 0.05) compared with group 2, despite similar age, BMI, and waist circumference. The relationship of the phenotype to atherosclerosis, however, was attenuated by adjustment for HDL cholesterol, triglyceride-rich lipoprotein cholesterol, apolipoprotein B, or LDL particle number. CONCLUSIONS: The presence of hypertriglyceridemic waist phenotype in subjects with type 2 diabetes identifies a subset with greater degree of visceral adiposity. This subset also has greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes.
Audience Professional
Author Theodore Mazzone
Steven Feinstein
George Kondos
Susan Sam
Michael H. Davidson
Ralph B. D'Agostino, Sr
Alfonso Perez
Steven Haffner
Author_xml – sequence: 1
  givenname: Susan
  surname: Sam
  fullname: Sam, Susan
  organization: Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Illinois, Chicago, Illinois
– sequence: 2
  givenname: Steven
  surname: Haffner
  fullname: Haffner, Steven
  organization: Department of Medicine, University of Texas Health Science Center, San Antonio, Texas
– sequence: 3
  givenname: Michael H.
  surname: Davidson
  fullname: Davidson, Michael H.
  organization: Pritzker School of Medicine, University of Chicago, Chicago, Illinois
– sequence: 4
  givenname: Ralph B.
  surname: D'Agostino
  fullname: D'Agostino, Ralph B.
  organization: Department of Mathematics, Statistics and Consulting Unit, Boston University, Boston, Massachusetts
– sequence: 5
  givenname: Steven
  surname: Feinstein
  fullname: Feinstein, Steven
  organization: Department of Medicine, Section of Cardiology, Rush University Medical Center, Chicago, Illinois
– sequence: 6
  givenname: George
  surname: Kondos
  fullname: Kondos, George
  organization: Department of Medicine, Section of Cardiology, University of Illinois College of Medicine, Chicago, Illinois
– sequence: 7
  givenname: Alfonso
  surname: Perez
  fullname: Perez, Alfonso
  organization: Takeda Global Research and Development, Deerfield, Illinois
– sequence: 8
  givenname: Theodore
  surname: Mazzone
  fullname: Mazzone, Theodore
  organization: Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, University of Illinois, Chicago, Illinois
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21997791$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19592623$$D View this record in MEDLINE/PubMed
BookMark eNp9kl9rFDEUxQep2G31wS8gg0VFZNr8nZm8CKVaWyhYsNrHkEnu7GaZzaxJVtlvb-Ku1ZZF8pCQ_M5Jcu85KPbc6KAonmN0TChtToxGokIMk0fFBAvKK85Zu1dMEGai4kKQ_eIghDlCiLG2fVLsY8EFqQmdFHCxXoKP3k6HtQZvDSysLm-VDbG8noEbYzovrz0Yq2MoL532oAKY8psNiVdDea5iaV35ZdXNISO3Ns7Km6wi5QerOogQnhaPezUEeLadD4uv5x9vzi6qq8-fLs9OrypdIxorzsAwjFTHVWtwbRQIzgliiHPTgMZGMFZ3PWNKKGg74A1vSIM6gyhlmnN6WLzf-C5X3QKMBhfTE-XS24XyazkqK--fODuT0_GHJA0ngrTJ4M3WwI_fVxCiXOR_DoNyMK6CbCjlohUtSeTr_5KsTj8RBCXw5QNwPq68S2WQhFBEa0TqBB1toKkaQFrXj-l5OjvKU4IT1FKS76x2UFNwuREpEr1N2_f44x18Gr-7vFPw4t_63RXuT14S8GoLqKDV0HvltA13HMFCNI3AiXu74bQfQ_DQ_7VCMmdW5szKnNnEnjxgtY0q2jG3yA47Fe82ipmdzn5aD9Jsg5YXWqUNSrIOC1zTX5sg-fU
CODEN DICAD2
CitedBy_id crossref_primary_10_1111_jcmm_14380
crossref_primary_10_1038_s41598_020_78883_1
crossref_primary_10_1016_j_med_2016_09_010
crossref_primary_10_3389_fnut_2022_980274
crossref_primary_10_1016_S0104_4230_12_70251_8
crossref_primary_10_3390_ijerph13040428
crossref_primary_10_3803_EnM_2014_29_4_514
crossref_primary_10_1007_s12020_019_01945_6
crossref_primary_10_1111_dme_12517
crossref_primary_10_1186_s12944_023_01795_2
crossref_primary_10_1111_jdi_12520
crossref_primary_10_1186_s12877_022_03547_w
crossref_primary_10_1111_ane_12925
crossref_primary_10_1016_j_diabres_2011_07_016
crossref_primary_10_1186_s12933_023_01834_3
crossref_primary_10_1007_s10903_014_9985_y
crossref_primary_10_1007_s00592_015_0715_2
crossref_primary_10_2217_clp_11_51
crossref_primary_10_1590_1516_3180_2016_004519102016
crossref_primary_10_1111_j_1365_2362_2012_02702_x
crossref_primary_10_1016_j_jcjd_2013_08_262
crossref_primary_10_15324_kjcls_2017_49_4_374
crossref_primary_10_1093_gerona_glv192
crossref_primary_10_2147_DMSO_S444084
crossref_primary_10_1016_j_dsx_2022_102524
crossref_primary_10_1016_j_jpedp_2012_08_006
crossref_primary_10_1371_journal_pgph_0001203
crossref_primary_10_1155_2020_9157430
crossref_primary_10_2147_DMSO_S257736
crossref_primary_10_2147_DMSO_S254741
crossref_primary_10_15324_kjcls_2023_55_2_113
crossref_primary_10_1371_journal_pone_0092322
crossref_primary_10_1016_j_rce_2020_06_013
crossref_primary_10_1111_dme_12052
crossref_primary_10_3390_ijerph13040368
crossref_primary_10_1161_ATVBAHA_110_207696
crossref_primary_10_1007_s40261_014_0175_4
crossref_primary_10_1186_1471_2261_12_78
crossref_primary_10_2147_DMSO_S259770
crossref_primary_10_1111_j_1464_5491_2011_03332_x
crossref_primary_10_1080_2331205X_2019_1639880
crossref_primary_10_2147_DMSO_S359742
crossref_primary_10_1097_JOM_0000000000002402
crossref_primary_10_1590_S0102_311X2013000500017
crossref_primary_10_1186_s12906_016_1024_1
crossref_primary_10_1186_s12986_020_00483_7
crossref_primary_10_1111_eci_12150
crossref_primary_10_1097_MD_0000000000005613
crossref_primary_10_1097_MD_0000000000000965
crossref_primary_10_1161_JAHA_117_008139
crossref_primary_10_1038_ijo_2010_127
crossref_primary_10_1186_1476_511X_13_38
crossref_primary_10_1371_journal_pone_0050992
crossref_primary_10_1016_j_amjms_2022_11_003
crossref_primary_10_1186_1756_0500_5_474
crossref_primary_10_1080_07315724_2019_1635052
crossref_primary_10_7759_cureus_31279
crossref_primary_10_18410_jebmh_2016_650
crossref_primary_10_1007_s40519_017_0476_8
crossref_primary_10_1016_j_ijcard_2013_01_275
crossref_primary_10_1038_ejcn_2012_83
crossref_primary_10_1016_j_medcli_2012_03_037
crossref_primary_10_1016_j_jad_2023_06_044
crossref_primary_10_1371_journal_pone_0025032
crossref_primary_10_1007_s12013_014_9906_7
crossref_primary_10_3389_fendo_2022_1024398
crossref_primary_10_1016_j_jdiacomp_2012_05_022
crossref_primary_10_1002_oby_20434
crossref_primary_10_1159_000477828
crossref_primary_10_1016_j_numecd_2015_09_004
crossref_primary_10_1016_j_psyneuen_2012_01_016
crossref_primary_10_1007_s10067_017_3559_z
crossref_primary_10_1017_S1368980016001270
crossref_primary_10_1016_j_orcp_2013_10_005
crossref_primary_10_1038_s41598_022_05806_7
crossref_primary_10_1016_j_metabol_2011_04_012
crossref_primary_10_7570_jomes_2018_27_3_166
crossref_primary_10_1590_s0004_2803_230302023_44
crossref_primary_10_18231_j_ijcbr_2020_098
crossref_primary_10_3390_nu15040912
crossref_primary_10_2217_dmt_11_22
crossref_primary_10_1016_j_rceng_2020_06_010
crossref_primary_10_1590_S0104_42302012000500014
crossref_primary_10_1016_j_orcp_2018_07_010
crossref_primary_10_1093_fampra_cmad047
crossref_primary_10_1038_nutd_2011_22
crossref_primary_10_1038_nutd_2014_16
crossref_primary_10_1371_journal_pone_0265629
crossref_primary_10_1038_s41598_021_00825_2
crossref_primary_10_1177_15579883231170172
crossref_primary_10_1038_s41598_024_59659_3
crossref_primary_10_1109_JBHI_2015_2396520
crossref_primary_10_3389_fpubh_2023_1213926
crossref_primary_10_1136_bmjopen_2022_071213
crossref_primary_10_1186_1471_2458_12_1081
crossref_primary_10_1002_oby_20096
crossref_primary_10_1007_s12170_011_0160_x
crossref_primary_10_1007_s42000_022_00374_x
crossref_primary_10_1186_s12944_018_0711_y
crossref_primary_10_1155_2018_1031939
crossref_primary_10_1186_s12872_021_01882_1
crossref_primary_10_1007_s40519_019_00677_w
crossref_primary_10_1016_j_medcli_2012_06_020
crossref_primary_10_1111_jdi_13685
crossref_primary_10_1016_j_jpeds_2012_09_051
crossref_primary_10_3390_nu15071722
crossref_primary_10_1371_journal_pone_0247600
crossref_primary_10_1089_met_2021_0019
crossref_primary_10_1097_SLA_0000000000000863
crossref_primary_10_1002_dmrr_1019
crossref_primary_10_3389_fendo_2023_1218905
crossref_primary_10_1186_1743_7075_8_21
crossref_primary_10_1016_j_ijcard_2014_03_177
crossref_primary_10_1016_j_niox_2015_08_002
crossref_primary_10_3906_biy_1512_40
crossref_primary_10_1016_j_ijdm_2010_05_011
crossref_primary_10_1038_ijo_2013_181
crossref_primary_10_1186_s13098_019_0450_x
crossref_primary_10_3390_nu17060937
crossref_primary_10_1016_j_jped_2013_02_009
crossref_primary_10_2147_DMSO_S302297
crossref_primary_10_1016_S2255_4823_12_70251_5
crossref_primary_10_1016_j_trsl_2014_05_008
Cites_doi 10.1161/01.ATV.21.6.961
10.1016/S0140-6736(05)66378-7
10.1152/jappl.2000.89.2.636
10.2337/diacare.25.4.696
10.1056/NEJMoa033179
10.1210/jc.2004-0432
10.1038/sj.ijo.0801871
10.1093/ajcn/88.3.645
10.1161/hc2901.093112
10.1210/jcem-68-1-191
10.1210/jc.2002-020570
10.1161/CIRCULATIONAHA.107.710509
10.1016/S0002-9149(96)00698-4
10.2337/diabetes.53.8.2087
10.1001/archinte.168.15.1609
10.2337/db06-0935
10.2337/db08-0157
10.2337/dc08-1856
10.1161/01.CIR.102.2.179
10.2337/diacare.24.2.335
10.1001/archinte.168.15.1617
10.1001/jama.296.21.joc60158
10.1161/ATVBAHA.107.159228
10.2337/diacare.26.5.1413
10.1038/sj.ijo.0801792
ContentType Journal Article
Copyright 2009 INIST-CNRS
COPYRIGHT 2009 American Diabetes Association
Copyright American Diabetes Association Oct 2009
2009 by the American Diabetes Association. 2009
Copyright_xml – notice: 2009 INIST-CNRS
– notice: COPYRIGHT 2009 American Diabetes Association
– notice: Copyright American Diabetes Association Oct 2009
– notice: 2009 by the American Diabetes Association. 2009
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X2
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ATCPS
AZQEC
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
M0K
M0R
M0S
M0T
M1P
M2O
M2P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
S0X
7S9
L.6
7X8
5PM
DOI 10.2337/dc09-0412
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Agricultural & Environmental Science & Pollution Managment
ProQuest Central Essentials
eLibrary
Proquest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Agricultural Science Database
Consumer Health Database
ProQuest Health & Medical Collection
Healthcare Administration Database
PML(ProQuest Medical Library)
Research Library
Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
SIRS Editorial
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest AP Science
SciTech Premium Collection
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Family Health
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Agricultural & Environmental Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE
Agricultural Science Database

MEDLINE - Academic
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 1920
ExternalDocumentID PMC2752928
1883662181
A210368322
19592623
21997791
10_2337_dc09_0412
diacare_32_10_1916
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: R01 DK071711
– fundername: NIDDK NIH HHS
  grantid: R56 DK071711
– fundername: NIDDK NIH HHS
  grantid: DK 71711
– fundername: National Institutes of Health
  grantid: DK 71711
GroupedDBID -
0R
1AW
29F
2WC
3V.
4.4
53G
5GY
5RE
5RS
5VS
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAIKC
AASXA
AAWTL
AAYEP
ABFLS
ABOCM
ABPPZ
ABPTK
ABUWG
ACGOD
ACJLH
ACVYA
ADACO
ADBBV
AENEX
AFKRA
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
ATCPS
AZQEC
BAWUL
BBAFP
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C1A
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
ET
EX3
F5P
FYUFA
GJ
GNUQQ
GUQSH
GX1
H13
HCIFZ
HZ
IAG
IAO
IEA
IGG
IHR
INH
INR
IOF
IPO
ITC
K9-
KM
KQ8
L7B
M0K
M0R
M0T
M1P
M2O
M2P
M2Q
M5
MBDVC
O0-
O5R
O5S
O9-
OK1
OVD
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
RHF
RHI
S0X
SJFOW
SV3
TDI
TWZ
WH7
WOQ
WOW
XZ
ZA5
---
-ET
..I
.GJ
.XZ
08P
0R~
18M
6PF
AAFWJ
AAKAS
AAMNW
AAYXX
ACGFO
ADZCM
AEGXH
AERZD
AFOSN
AIAGR
ALIPV
BTFSW
CCPQU
CITATION
EMOBN
HMCUK
HZ~
M5~
N4W
NAPCQ
PHGZM
PHGZT
TEORI
TR2
UKHRP
VVN
W8F
YHG
YOC
~KM
.55
3O-
41~
8F7
AAQOH
AAQQT
AAYJJ
AFFNX
AI.
IQODW
J5H
PJZUB
PPXIY
VH1
WHG
X7M
ZCG
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
K9.
PKEHL
Q9U
7S9
L.6
7X8
5PM
ID FETCH-LOGICAL-c603t-54ed410ab5a8d16dae955204055d7ec1d9446bf44a9ae8be5757270bd0334c553
IEDL.DBID 7X7
ISSN 0149-5992
1935-5548
IngestDate Thu Aug 21 13:59:06 EDT 2025
Tue Aug 05 11:29:21 EDT 2025
Fri Jul 11 06:48:18 EDT 2025
Sat Jul 26 02:21:22 EDT 2025
Tue Jun 17 21:57:40 EDT 2025
Thu Jun 12 23:57:55 EDT 2025
Tue Jun 10 20:58:36 EDT 2025
Mon Jul 21 06:04:24 EDT 2025
Mon Jul 21 09:14:19 EDT 2025
Tue Jul 01 04:20:20 EDT 2025
Thu Apr 24 22:54:17 EDT 2025
Fri Jan 15 19:48:12 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Endocrinopathy
Type 2 diabetes
Visceral fat
Human
Nutrition
Prediction
Lipids
Metabolic diseases
Hyperlipoproteinemia
Lipoprotein
Triglyceride
Enzymopathy
Phenotype
Hypertriglyceridemia
Dyslipemia
Predictive factor
Endocrinology
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c603t-54ed410ab5a8d16dae955204055d7ec1d9446bf44a9ae8be5757270bd0334c553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC2752928
PMID 19592623
PQID 223036026
PQPubID 47715
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2752928
proquest_miscellaneous_733598982
highwire_diabetes_diacare_32_10_1916
proquest_miscellaneous_46410920
pubmed_primary_19592623
crossref_citationtrail_10_2337_dc09_0412
pascalfrancis_primary_21997791
proquest_journals_223036026
gale_infotracgeneralonefile_A210368322
gale_infotracmisc_A210368322
crossref_primary_10_2337_dc09_0412
gale_infotracacademiconefile_A210368322
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-10-01
PublicationDateYYYYMMDD 2009-10-01
PublicationDate_xml – month: 10
  year: 2009
  text: 2009-10-01
  day: 01
PublicationDecade 2000
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: Alexandria
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 2009
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Perry (2022031218163762800_B10) 2000; 89
Mazzone (2022031218163762800_B8) 2007; 56
Terry (2022031218163762800_B20) 1989; 68
Sam (2022031218163762800_B9) 2008; 57
Lemieux (2022031218163762800_B5) 2000; 102
Ross (2022031218163762800_B12) 2002; 87
Carr (2022031218163762800_B21) 2004; 53
Thorne (2022031218163762800_B14) 2002; 26
Lemieux (2022031218163762800_B15) 2001; 21
Wildman (2022031218163762800_B1) 2008; 168
Despres (2022031218163762800_B6) 2008; 28
Keelan (2022031218163762800_B24) 2001; 104
Hosoi (2022031218163762800_B23) 2002; 25
Festa (2022031218163762800_B16) 2001; 25
Guerci (2022031218163762800_B22) 1997; 79
Mazzone (2022031218163762800_B7) 2006; 296
Nicklas (2022031218163762800_B11) 2003; 26
Pou (2022031218163762800_B17) 2007; 116
Ding (2022031218163762800_B18) 2008; 88
Klein (2022031218163762800_B13) 2004; 350
Carr (2022031218163762800_B4) 2004; 89
Eckel (2022031218163762800_B3) 2005; 365
Stefan (2022031218163762800_B2) 2008; 168
Schurgin (2022031218163762800_B25) 2001; 24
Sam (2022031218163762800_B19) 2009; 32
11397704 - Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):961-7
18695075 - Arch Intern Med. 2008 Aug 11;168(15):1617-24
2909551 - J Clin Endocrinol Metab. 1989 Jan;68(1):191-9
12716798 - Diabetes Care. 2003 May;26(5):1413-20
11850750 - Int J Obes Relat Metab Disord. 2002 Feb;26(2):193-9
11919127 - Diabetes Care. 2002 Apr;25(4):696-701
17709633 - Circulation. 2007 Sep 11;116(11):1234-41
11468202 - Circulation. 2001 Jul 24;104(4):412-7
12414870 - J Clin Endocrinol Metab. 2002 Nov;87(11):5044-51
18779279 - Am J Clin Nutr. 2008 Sep;88(3):645-50
18695074 - Arch Intern Med. 2008 Aug 11;168(15):1609-16
15201411 - N Engl J Med. 2004 Jun 17;350(25):2549-57
11673759 - Int J Obes Relat Metab Disord. 2001 Oct;25(10):1407-15
10889128 - Circulation. 2000 Jul 11;102(2):179-84
17101640 - JAMA. 2006 Dec 6;296(21):2572-81
15277390 - Diabetes. 2004 Aug;53(8):2087-94
18469202 - Diabetes. 2008 Aug;57(8):2022-7
18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
17327456 - Diabetes. 2007 Mar;56(3):849-55
9193010 - Am J Cardiol. 1997 Jan 15;79(2):128-33
19228869 - Diabetes Care. 2009 May;32(5):932-7
11213888 - Diabetes Care. 2001 Feb;24(2):335-8
10926648 - J Appl Physiol (1985). 2000 Aug;89(2):636-43
15836891 - Lancet. 2005 Apr 16-22;365(9468):1415-28
15181030 - J Clin Endocrinol Metab. 2004 Jun;89(6):2601-7
References_xml – volume: 21
  start-page: 961
  year: 2001
  ident: 2022031218163762800_B15
  article-title: Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.21.6.961
– volume: 365
  start-page: 1415
  year: 2005
  ident: 2022031218163762800_B3
  article-title: The metabolic syndrome
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66378-7
– volume: 89
  start-page: 636
  year: 2000
  ident: 2022031218163762800_B10
  article-title: Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables
  publication-title: J Appl Physiol
  doi: 10.1152/jappl.2000.89.2.636
– volume: 25
  start-page: 696
  year: 2002
  ident: 2022031218163762800_B23
  article-title: Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients
  publication-title: Diabetes Care
  doi: 10.2337/diacare.25.4.696
– volume: 350
  start-page: 2549
  year: 2004
  ident: 2022031218163762800_B13
  article-title: Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa033179
– volume: 89
  start-page: 2601
  year: 2004
  ident: 2022031218163762800_B4
  article-title: Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2004-0432
– volume: 26
  start-page: 193
  year: 2002
  ident: 2022031218163762800_B14
  article-title: A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0801871
– volume: 88
  start-page: 645
  year: 2008
  ident: 2022031218163762800_B18
  article-title: Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/88.3.645
– volume: 104
  start-page: 412
  year: 2001
  ident: 2022031218163762800_B24
  article-title: Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography
  publication-title: Circulation
  doi: 10.1161/hc2901.093112
– volume: 68
  start-page: 191
  year: 1989
  ident: 2022031218163762800_B20
  article-title: Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jcem-68-1-191
– volume: 87
  start-page: 5044
  year: 2002
  ident: 2022031218163762800_B12
  article-title: Abdominal obesity, muscle composition, and insulin resistance in premenopausal women
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-020570
– volume: 116
  start-page: 1234
  year: 2007
  ident: 2022031218163762800_B17
  article-title: Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.710509
– volume: 79
  start-page: 128
  year: 1997
  ident: 2022031218163762800_B22
  article-title: Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(96)00698-4
– volume: 53
  start-page: 2087
  year: 2004
  ident: 2022031218163762800_B21
  article-title: Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome
  publication-title: Diabetes
  doi: 10.2337/diabetes.53.8.2087
– volume: 168
  start-page: 1609
  year: 2008
  ident: 2022031218163762800_B2
  article-title: Identification and characterization of metabolically benign obesity in humans
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.168.15.1609
– volume: 56
  start-page: 849
  year: 2007
  ident: 2022031218163762800_B8
  article-title: Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/db06-0935
– volume: 57
  start-page: 2022
  year: 2008
  ident: 2022031218163762800_B9
  article-title: Relationship of abdominal visceral and subcutaneous adipose tissue to lipoprotein particle number and size in type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/db08-0157
– volume: 32
  start-page: 932
  year: 2009
  ident: 2022031218163762800_B19
  article-title: Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1856
– volume: 102
  start-page: 179
  year: 2000
  ident: 2022031218163762800_B5
  article-title: Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.2.179
– volume: 24
  start-page: 335
  year: 2001
  ident: 2022031218163762800_B25
  article-title: Increased prevalence of significant coronary artery calcification in patients with diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.24.2.335
– volume: 168
  start-page: 1617
  year: 2008
  ident: 2022031218163762800_B1
  article-title: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004)
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.168.15.1617
– volume: 296
  start-page: 2572
  year: 2006
  ident: 2022031218163762800_B7
  article-title: Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial
  publication-title: JAMA
  doi: 10.1001/jama.296.21.joc60158
– volume: 28
  start-page: 1039
  year: 2008
  ident: 2022031218163762800_B6
  article-title: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.159228
– volume: 26
  start-page: 1413
  year: 2003
  ident: 2022031218163762800_B11
  article-title: Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.5.1413
– volume: 25
  start-page: 1407
  year: 2001
  ident: 2022031218163762800_B16
  article-title: The relation of body fat mass and distribution to markers of chronic inflammation
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0801792
– reference: 11673759 - Int J Obes Relat Metab Disord. 2001 Oct;25(10):1407-15
– reference: 12716798 - Diabetes Care. 2003 May;26(5):1413-20
– reference: 15181030 - J Clin Endocrinol Metab. 2004 Jun;89(6):2601-7
– reference: 15201411 - N Engl J Med. 2004 Jun 17;350(25):2549-57
– reference: 18469202 - Diabetes. 2008 Aug;57(8):2022-7
– reference: 11213888 - Diabetes Care. 2001 Feb;24(2):335-8
– reference: 18695075 - Arch Intern Med. 2008 Aug 11;168(15):1617-24
– reference: 2909551 - J Clin Endocrinol Metab. 1989 Jan;68(1):191-9
– reference: 18779279 - Am J Clin Nutr. 2008 Sep;88(3):645-50
– reference: 11397704 - Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):961-7
– reference: 18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49
– reference: 15277390 - Diabetes. 2004 Aug;53(8):2087-94
– reference: 10889128 - Circulation. 2000 Jul 11;102(2):179-84
– reference: 11919127 - Diabetes Care. 2002 Apr;25(4):696-701
– reference: 17101640 - JAMA. 2006 Dec 6;296(21):2572-81
– reference: 17709633 - Circulation. 2007 Sep 11;116(11):1234-41
– reference: 9193010 - Am J Cardiol. 1997 Jan 15;79(2):128-33
– reference: 17327456 - Diabetes. 2007 Mar;56(3):849-55
– reference: 10926648 - J Appl Physiol (1985). 2000 Aug;89(2):636-43
– reference: 19228869 - Diabetes Care. 2009 May;32(5):932-7
– reference: 11468202 - Circulation. 2001 Jul 24;104(4):412-7
– reference: 15836891 - Lancet. 2005 Apr 16-22;365(9468):1415-28
– reference: 12414870 - J Clin Endocrinol Metab. 2002 Nov;87(11):5044-51
– reference: 18695074 - Arch Intern Med. 2008 Aug 11;168(15):1609-16
– reference: 11850750 - Int J Obes Relat Metab Disord. 2002 Feb;26(2):193-9
SSID ssj0004488
Score 2.3521821
Snippet Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes Susan Sam , MD 1 , Steven Haffner , MD 2 , Michael H....
Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not always...
OBJECTIVE: Greater accumulation of visceral fat is strongly linked to risk of cardiovascular disease. However, elevated waist circumference by itself does not...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1916
SubjectTerms adiposity
Aged
apolipoprotein B
atherosclerosis
Biological and medical sciences
Blood cholesterol
Body fat
body mass index
calcium
Cardiovascular disease
Complications and side effects
coronary vessels
Data analysis
Diabetes
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - pathology
Diabetes. Impaired glucose tolerance
Diagnosis
Disorders of blood lipids. Hyperlipoproteinemia
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Genotype & phenotype
high density lipoprotein cholesterol
Humans
Hyperlipidemia
Hypertriglyceridemia
Hypertriglyceridemia - physiopathology
Intra-Abdominal Fat
Intra-Abdominal Fat - metabolism
Intra-Abdominal Fat - physiopathology
low density lipoprotein
Male
Measurement
Medical sciences
men
Metabolic diseases
Metabolic syndrome
metabolism
Middle Aged
Miscellaneous
noninsulin-dependent diabetes mellitus
Original Research
pathology
phenotype
Physiological aspects
physiology
physiopathology
Public health. Hygiene
Public health. Hygiene-occupational medicine
R&D
Racial differences
Research & development
Risk factors
Statins
Statistical methods
Studies
Tomography
triacylglycerols
Type 2 diabetes
visceral fat
waist
waist circumference
Waist Circumference - physiology
women
Title Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes
URI http://care.diabetesjournals.org/content/32/10/1916.abstract
https://www.ncbi.nlm.nih.gov/pubmed/19592623
https://www.proquest.com/docview/223036026
https://www.proquest.com/docview/46410920
https://www.proquest.com/docview/733598982
https://pubmed.ncbi.nlm.nih.gov/PMC2752928
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF5BKyEuiDemJaxQBVys2vuwd0-oVI0ipFYRojS3lb0PEqlySuwe-PfM-JFiFLhEkXYSjXdmZ3dmP39DyJGSwutU2bh0ZRYLodNYKR3i4JIkeJEH1vZYOr_IZpfiy0IuemxO3cMqh5jYBmq3tlgjP4ZtDIItZAyfbn7G2DQKL1f7Dhr3yT4yl2HulS_yu9ciRdt2EpOAWGrNOmIhxnl-7Gx7J5Cy0XY0BOWBKRiBkkUNcxW6Jhe7TqF_gyn_2J2mj8mj_lhJTzo_eELu-eopeXDeX5w_I34G-eamgQe6_mXB6VpMPL0qwMh0vvTVGkuxdL7BHzQ1haiBYHXv6PdVbbFsRadFQ1cVhUCDlZuaXq2aJcUsljLaw2rq5-RyevbtdBb3HRZimyW8icFQTqRJUcpCuTRzhddSMljXUrrc29RpyBbLIARyeKvSw9kOzjtJ6RLOhZWSvyB71bryrwhlCbfBpswqz4QvgtKJDMpxHngmlHMR-ThMtLE9_Th2wbg2kIagTQzaxKBNIvJuK3rTcW7sEvqA1jK4DuF_bNG_TgDaIKOVOYFclmcYryLyfiT5o-Pz3iV4OBKEhWZHw0eDY5ihMI5fEKJnOEMVIfnNIjIZOc32ERhienKdRuRg8CLTB4zabN07Im-3o6gAYuAqv76tjcjAVJolEaH_kMg58jFqBaq-7Jzybv60RGZIHpF85K5bAaQZH49Uq2VLN85yyTRTr_-r9gF52N6ztTDHQ7LXbG79GziuNeWkXZTwqU7TCdn_fHYx__obIWdBnA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxJvQ0lqoPC5REz8S-4BQVVht6UM9tLQ3k9gOu1KVLZtUqD-K_8hMHluCFm69RfLsauIZjz3jL98QsqWk8DpWNsxdnoRC6DhUShdh4aKo8CItWNNj6fAoGZ-KL-fyfIX86r-FQVhlHxObQO1mFmvk27CNQbCFjOHj5Y8Qm0bh5WrfQaP1in1__RMyturD3icw7xvGRp9Pdsdh11QgtEnE6xB0cyKOslxmysWJy7yWkoErS-lSb2OnIUHKCyGQtlrlHo4zsMVHuYs4F1ZikwiI-HcE5ylS9avdG0QJZDqqRUzqUGrNWiIjBpLbzjZ3EDEbbH_9JtAzEyMwM6vANkXbVGPZqfdv8OYfu-HoIXnQHWPpTut3j8iKLx-Tu4fdRf0T4seQ385rmMCLawtO3mDw6VkGTkWPJ76cYemXHs_xB3VFIUohON47-nVaWSyT0VFW02lJIbBhpaiiZ9N6QjFrpox2MJ7qKTm9lcl_RlbLWelfEMoibgsbM6s8Ez4rlI5koRznBU-Eci4g7_uJNrajO8euGxcG0h60iUGbGLRJQF4vRC9bjo9lQu_QWgbXPfyPzbrPF0AbZNAyO5A78wTjY0DeDiS_t_zhywTXB4KwsO1geKt3DNMX4vEBIYGGM1QRku0kIBsDp1m8AkMMUarjgKz1XmS6AFWZxXIKyOZiFBVAzF3pZ1eVEQmYSrMoIPQfEilH_ketQNXnrVPezJ-WyETJA5IO3HUhgLTmw5FyOmnozVkqmWbq5X_V3iT3xieHB-Zg72h_jdxv7vgaiOU6Wa3nV_4VHBXrfKNZoJR8u-2I8BuNL3sw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlVcEG9CS2uh8rhETfxI7ANCFWW1pbTaA6V7M4ntsCtV2bJJhfrT-HfM5LElqHDrbSXPrmY942889ucZQnaVFF7Hyoa5y5NQCB2HSukiLFwUFV6kBWt6LB2fJONT8Wkqp2vkV_8WBmmVPSY2QO0WFs_I9yCMAdhCxrBXdKyIycHo_cWPEBtI4UVr302j9ZAjf_UTsrfq3eEBmPoVY6OPXz6Mw67BQGiTiNch6OlEHGW5zJSLE5d5LSUDt5bSpd7GTkOylBdCYAlrlXvY2kC4j3IXcS6sxIYRgP53Ug5RE5ZSOk2vn2SKpuUlJiCh1Jq1RY0Y5-mes819RMwGobAPCH2VYiRpZhXYqWgbbNy0A_6byPlHZBzdJ_e6LS3db33wAVnz5UOycdxd2j8ifgy57rKGCTy_suDwDR-fnmXgYHQy8-UCj4HpZIlfqCsKiIVEee_o13ll8ciMjrKazksKIIenRhU9m9czihk0ZbSj9FSPyemtTP4Tsl4uSv-MUBZxW9iYWeWZ8FmhdCQL5TgveCKUcwF520-0sV3pc-zAcW4gBUKbGLSJQZsE5OVK9KKt93GT0Bu0lkEMgN-xWfeUAbTBalpmH_JoniBWBuT1QPJ7W0v8JsGtgSAscjsY3u0dw_SH8vgB6YGGM1QREu8kINsDp1n9BYZ8olTHAdnsvch0YFWZ1dIKyM5qFBVA_l3pF5eVEQmYSrMoIPQfEinHWpBagapPW6e8nj8tsSolD0g6cNeVAJY4H46U81lT6pylkmmmnv9X7R2yAVhgPh-eHG2Su811X8O23CLr9fLSv4BdY51vN-uTkm-3DQi_AamUf5I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypertriglyceridemic+waist+phenotype+predicts+increased+visceral+fat+in+subjects+with+type+2+diabetes&rft.jtitle=Diabetes+care&rft.au=Sam%2C+Susan&rft.au=Haffner%2C+Steven&rft.au=Davidson%2C+Michael+H&rft.au=D%27Agostino%2C+Sr%2C+Ralph+B&rft.date=2009-10-01&rft.eissn=1935-5548&rft.volume=32&rft.issue=10&rft.spage=1916&rft_id=info:doi/10.2337%2Fdc09-0412&rft_id=info%3Apmid%2F19592623&rft.externalDocID=19592623
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon